{"id":"https://openalex.org/W2102387844","doi":"https://doi.org/10.1200/jco.2007.14.9062","title":"Of Mice and (Wo)Men: Is This Any Way to Test a New Drug?","display_name":"Of Mice and (Wo)Men: Is This Any Way to Test a New Drug?","publication_year":2008,"publication_date":"2008-02-16","ids":{"openalex":"https://openalex.org/W2102387844","doi":"https://doi.org/10.1200/jco.2007.14.9062","mag":"2102387844","pmid":"https://pubmed.ncbi.nlm.nih.gov/18281652"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.14.9062","doi":"https://doi.org/10.1200/jco.2007.14.9062","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.14.9062","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031366322","display_name":"Tufia C. Haddad","orcid":"https://orcid.org/0000-0001-8226-3581","observed_orcids":["https://orcid.org/0000-0001-8226-3581"]},"institutions":[{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tufia C. Haddad","raw_affiliation_strings":["University of Minnesota Cancer Center, Minneapolis, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota Cancer Center, Minneapolis, MN","institution_ids":["https://openalex.org/I4390039358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033966004","display_name":"Douglas Yee","orcid":"https://orcid.org/0000-0002-3387-4009","observed_orcids":["https://orcid.org/0000-0002-3387-4009"]},"institutions":[{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Yee","raw_affiliation_strings":["University of Minnesota Cancer Center, Minneapolis, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota Cancer Center, Minneapolis, MN","institution_ids":["https://openalex.org/I4390039358"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4390039358"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"6","first_page":"830","last_page":"832"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.7143999934196472,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.7143999934196472,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.17110000550746918,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.041099999099969864,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/preclinical-drug-testing","display_name":"preclinical drug testing","score":0.7120000123977661},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.9160000085830688},{"id":"https://openalex.org/keywords/genetically-engineered-mouse-models","display_name":"genetically engineered mouse models","score":0.9950000047683716},{"id":"https://openalex.org/keywords/orthotopic-transplantation","display_name":"orthotopic transplantation","score":0.6660000085830688},{"id":"https://openalex.org/keywords/drug-efficacy-prediction","display_name":"drug efficacy prediction","score":0.4339999854564667},{"id":"https://openalex.org/keywords/translational-research","display_name":"translational research","score":0.5460000038146973},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8989999890327454},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6299999952316284},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6240000128746033},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.4959999918937683},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6859999895095825},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5360000133514404},{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.9369999766349792},{"id":"https://openalex.org/keywords/toxicity-assessment","display_name":"toxicity prediction","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8092358112335205},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5831829309463501},{"id":"https://openalex.org/C2777267654","wikidata":"https://www.wikidata.org/wiki/Q3519023","display_name":"Test (biology)","level":2,"score":0.5031663775444031},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40864014625549316},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38468503952026367},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019394","descriptor_name":"Ki-67 Antigen","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019394","descriptor_name":"Ki-67 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2007.14.9062","doi":"https://doi.org/10.1200/jco.2007.14.9062","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.14.9062","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:18281652","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18281652","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1453600927","https://openalex.org/W1562190372","https://openalex.org/W1612068869","https://openalex.org/W1895993106","https://openalex.org/W1969066719","https://openalex.org/W1992252639","https://openalex.org/W1995277205","https://openalex.org/W2001679453","https://openalex.org/W2006174096","https://openalex.org/W2071275412","https://openalex.org/W2082117763","https://openalex.org/W2115759102","https://openalex.org/W2123391236","https://openalex.org/W2123945948","https://openalex.org/W2149908785"],"related_works":["https://openalex.org/W159782486","https://openalex.org/W2120191503","https://openalex.org/W12764995","https://openalex.org/W2001679453","https://openalex.org/W1998534698","https://openalex.org/W1984250533","https://openalex.org/W1547369320","https://openalex.org/W2471729367","https://openalex.org/W2016636248","https://openalex.org/W2155413956"],"abstract_inverted_index":{"Mouse":[0],"models":[1,107,312,321,460,492,505],"are":[2,150,161,297,493],"undeniably":[3],"vital":[4],"to":[5,32,265,318,340,363,417,430,433,457,488,525,560,606,613,663,719,735,779],"our":[6],"understanding":[7],"of":[8,14,26,55,66,78,124,132,139,146,179,233,239,250,292,395,406,455,466,543,549,555,563,591,640,666,689,696,738,755],"the":[9,24,53,64,76,86,140,147,155,164,168,176,192,234,240,251,262,267,287,400,404,421,453,541,581,627,638,664,671,687,692,703,736,753],"molecular":[10,142,477],"basis":[11],"and":[12,36,69,88,97,143,163,205,276,345,385,410,435,530,545,630,642,694,763,775,783],"pathogenesis":[13,693],"breast":[15,511,519,566,646,697,761],"cancer.":[16],"In":[17],"addition,":[18],"they":[19,324],"provide":[20,325],"valuable":[21],"information":[22],"for":[23,371,496,764,786],"development":[25,77,178,329,360,472,665,737],"novel":[27],"antineoplastic":[28],"agents":[29],"with":[30,480,589,599,618,650,757,769],"regard":[31],"basic":[33,56],"pharmacokinetics,":[34],"pharmacogenomics,":[35],"toxicity":[37],"analysis.":[38],"Their":[39,173,334],"role":[40,357,688],"in":[41,52,71,99,121,152,175,217,222,228,245,256,272,281,299,322,326,330,350,358,528,531,539,546,570,580,596,626,648,657,691,709,725,752,767],"evaluating":[42,497],"cancer":[43,294,343,451,512,520,567,647,668,698,762],"drug":[44,199,270,359,471],"efficacy,":[45],"however,":[46,81,183,576],"has":[47,747],"been":[48,119,661],"limited":[49],"by":[50,186,286,348],"inconsistencies":[51],"translation":[54],"science":[57],"into":[58,128,510],"effective":[59],"clinical":[60,213,257,279,353,594,750],"treatments.":[61],"Ideally,":[62],"mimicking":[63],"intricacies":[65],"human":[67,109,208,300,352,376,386,396,450,515,565,593,726],"tumorigenesis":[68],"metastasis":[70],"model":[72,203,445,535],"systems":[73,204],"would":[74],"simplify":[75],"targeted":[79,667],"therapeutics;":[80],"modeling":[82],"such":[83,159,467,501],"interplay":[84],"between":[85,201,269,383],"tumor":[87,110,148,169,328,397,408,727],"its":[89,558],"surrounding":[90,158],"stroma,":[91],"matrix":[92],"proteins,":[93],"immune":[94],"cells,":[95],"endothelia,":[96],"lymphatics":[98],"mice":[100,658],"is":[101,170,184,261,284,337,380,423,486,632],"a":[102,315,464,608,740],"seemingly":[103],"insurmountable":[104],"task.":[105],"Xenograft":[106],"employ":[108],"cells":[111,149,522],"isolated":[112],"from":[113,191,645],"metastatic":[114,602,760],"deposits":[115],"that":[116,212,242,289,296,323,634,730,746],"may":[117,436],"have":[118,313,506,607,659,720,777],"passaged":[120],"vitro":[122,529],"hundreds":[123],"times":[125],"before":[126],"injection":[127],"an":[129,133,187,331],"orthotopic":[130],"site":[131],"immunodeficient":[134],"mouse":[135,275,311,384,444,491,504,710],"host.":[136],"Although":[137,259,413,441],"some":[138],"original":[141],"cellular":[144],"pathways":[145],"preserved":[151],"cell":[153,568,583,728],"lines,":[154],"macroand":[156],"microenvironment":[157],"tumors":[160],"artificial,":[162],"true":[165],"heterogeneity":[166],"within":[167],"likely":[171,462],"compromised.":[172],"value":[174],"historical":[177],"cytotoxic":[180,482],"chemotherapeutic":[181,483],"agents,":[182],"supported":[185],"extensive":[188],"retrospective":[189],"analysis":[190],"National":[193],"Cancer":[194],"Institute.":[195],"This":[196,366,534,733],"study":[197],"compared":[198,479],"activity":[200,214,225],"xenograft":[202,224,274,320,532],"phase":[206,278,304],"II":[207,305],"participants.":[209],"It":[210],"demonstrated":[211,557,748],"was":[215,226,537,577,699,717],"absent":[216],"all":[218,293],"six":[219],"chemotherapy":[220],"drugs":[221,241],"which":[223,597],"observed":[227,579,625],"less":[229],"than":[230,247,615],"one":[231,248,443],"third":[232,249],"xenografts":[235,252],"tested,":[236],"whereas":[237],"45%":[238],"were":[243,253,523,587,604,623,707],"active":[244,255],"more":[246],"also":[254,624,660],"subjects.":[258],"this":[260,414],"best":[263],"evidence":[264],"support":[266],"correlation":[268],"efficacy":[271],"preclinical":[273],"early":[277,553],"studies":[280,301,554],"humans,":[282],"it":[283,485,631],"tempered":[285],"fact":[288],"only":[290],"17%":[291],"therapies":[295,669],"evaluated":[298],"will":[302,461],"survive":[303],"evaluation.":[306],"More":[307],"recently,":[308],"genetically":[309],"engineered":[310],"become":[314],"promising":[316],"alternative":[317],"traditional":[319],"situ":[327],"immunocompetent":[332],"setting.":[333],"major":[335],"limitation":[336],"their":[338,356,481,498],"inability":[339],"replicate":[341],"advanced":[342],"states":[344],"metastases\u2014characteristics":[346],"shared":[347],"participants":[349],"early-phase":[351],"trials.":[354],"Thus,":[355],"yet":[361],"remains":[362],"be":[364,368,391,438,526,780],"defined.":[365],"can":[367,447],"particularly":[369],"troublesome":[370],"monoclonal":[372,715],"antibodies":[373],"directed":[374],"against":[375,670,702],"targets.":[377],"Unless":[378],"there":[379],"substantial":[381],"cross-reactivity":[382],"epitopes,":[387],"host/antibody":[388],"interactions":[389],"cannot":[390],"modeled.":[392],"Orthotopic":[393],"transplantation":[394],"xenografts,":[398],"on":[399],"other":[401,418],"hand,":[402],"promotes":[403],"establishment":[405],"high":[407],"volume":[409],"distant":[411],"metastases.":[412],"seems":[415],"preferable":[416],"assessable":[419],"systems,":[420],"technology":[422],"labor":[424],"intensive,":[425],"expensive,":[426],"requires":[427],"small-animal":[428],"imaging":[429],"monitor":[431],"response":[432,611],"therapy,":[434],"not":[437,578,653],"easily":[439],"reproducible.":[440],"no":[442],"system":[446,536],"perfectly":[448],"simulate":[449],"biology,":[452],"ability":[454],"scientists":[456],"humanize":[458],"these":[459],"require":[463],"combination":[465],"methodologies.":[468],"As":[469,686],"contemporary":[470],"takes":[473],"aim":[474],"at":[475],"specific":[476,721],"targets,":[478],"predecessors,":[484],"fair":[487],"question":[489],"whether":[490],"even":[494],"appropriate":[495],"efficacy.":[499],"Despite":[500],"flaws,":[502],"imperfect":[503],"provided":[507],"important":[508,538,781],"insights":[509],"therapy.":[513,551],"Cultured":[514],"estrogen":[516],"receptor":[517,675,684,706],"(ER)-positive":[518],"MCF-7":[521],"found":[524,605],"estrogen-dependent":[527],"models.":[533,711],"discovering":[540],"mechanisms":[542],"action":[544],"vivo":[547],"effects":[548,724],"antiestrogen":[550],"Indeed,":[552],"tamoxifen":[556,614,635],"capacity":[559],"induce":[561],"regression":[562],"ER-positive":[564],"lines":[569,729],"nude":[571],"mice.":[572],"Such":[573],"growth":[574,673,682],"inhibition,":[575],"ER-negative":[582,619],"lines.":[584],"These":[585],"results":[586,622],"consistent":[588],"those":[590,617],"subsequent":[592],"trials":[595],"women":[598,649,756,768],"advanced,":[600],"ER-positive,":[601,651],"disease":[603],"significantly":[609,636],"higher":[610],"rate":[612],"did":[616],"tumors.":[620],"Similar":[621],"adjuvant":[628,765],"setting,":[629],"clear":[633],"reduces":[637],"odds":[639],"recurrence":[641],"death":[643],"resulting":[644],"but":[652],"ER-negative,":[654],"disease.":[655,772],"Studies":[656],"crucial":[662],"epidermal":[672,681],"factor":[674,683],"(EGFR)":[676],"family,":[677],"including":[678],"HER-2":[679,776],"(human":[680],"2).":[685],"HER-2/neu":[690],"progression":[695],"defined,":[700],"inhibitors":[701],"surface":[704],"membrane":[705],"generated":[708],"The":[712],"4D5":[713],"murine":[714,743],"antibody":[716,745],"shown":[718],"dose-dependent":[722],"antiproliferative":[723],"overexpress":[731],"HER-2.":[732],"led":[734],"trastuzumab,":[739],"recombinant,":[741],"humanized":[742],"anti\u2013HER-2":[744],"significant":[749],"benefit":[751],"treatment":[754],"HER-2\u2013":[758],"overexpressing":[759],"therapy":[766],"resected":[770],"early-stage":[771],"Both":[773],"ER":[774],"proven":[778],"prognostically":[782],"as":[784],"biomarkers":[785],"JOURNAL":[787],"OF":[788],"CLINICAL":[789],"ONCOLOGY":[790],"E":[791],"D":[792],"I":[793,797],"T":[794],"O":[795],"R":[796],"A":[798],"L":[799],"VOLUME":[800],"26":[801],"NUMBER":[802],"6":[803],"FEBRUARY":[804],"2":[805]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}